Galanko JA - Search Results

1

Suppressor of cytokine signaling 3 (SOCS3) is not an independent biomarker of colorectal adenoma risk.

Hamilton KE, Lund PK, Galanko JA, Sandler RS, Keku TO. Hamilton KE, et al. Among authors: galanko ja. BMC Res Notes. 2010 May 25;3:144. doi: 10.1186/1756-0500-3-144. BMC Res Notes. 2010. PMID: 20500855 Free PMC article.

2

Nonsteroidal anti-inflammatory drugs, apoptosis, and colorectal adenomas.

Martin C, Connelly A, Keku TO, Mountcastle SB, Galanko J, Woosley JT, Schliebe B, Lund PK, Sandler RS. Martin C, et al. Gastroenterology. 2002 Dec;123(6):1770-7. doi: 10.1053/gast.2002.37053. Gastroenterology. 2002. PMID: 12454832

3

Association between hemochromatosis (HFE) gene mutation carrier status and the risk of colon cancer.

Shaheen NJ, Silverman LM, Keku T, Lawrence LB, Rohlfs EM, Martin CF, Galanko J, Sandler RS. Shaheen NJ, et al. J Natl Cancer Inst. 2003 Jan 15;95(2):154-9. doi: 10.1093/jnci/95.2.154. J Natl Cancer Inst. 2003. PMID: 12529348

4

Constipation, laxative use, and colon cancer in a North Carolina population.

Roberts MC, Millikan RC, Galanko JA, Martin C, Sandler RS. Roberts MC, et al. Among authors: galanko ja. Am J Gastroenterol. 2003 Apr;98(4):857-64. doi: 10.1111/j.1572-0241.2003.07386.x. Am J Gastroenterol. 2003. PMID: 12738468

5

Insurance, employment, and psychosocial consequences of a diagnosis of hereditary hemochromatosis in subjects without end organ damage.

Shaheen NJ, Lawrence LB, Bacon BR, Barton JC, Barton NH, Galanko J, Martin CF, Burnett CK, Sandler RS. Shaheen NJ, et al. Am J Gastroenterol. 2003 May;98(5):1175-80. doi: 10.1111/j.1572-0241.2003.07405.x. Am J Gastroenterol. 2003. PMID: 12809845

6

Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial.

Sandborn WJ, Present DH, Isaacs KL, Wolf DC, Greenberg E, Hanauer SB, Feagan BG, Mayer L, Johnson T, Galanko J, Martin C, Sandler RS. Sandborn WJ, et al. Gastroenterology. 2003 Aug;125(2):380-8. doi: 10.1016/s0016-5085(03)00877-1. Gastroenterology. 2003. PMID: 12891539 Clinical Trial.

7

Associations of micronutrients with colon cancer risk in African Americans and whites: results from the North Carolina Colon Cancer Study.

Satia-Abouta J, Galanko JA, Martin CF, Potter JD, Ammerman A, Sandler RS. Satia-Abouta J, et al. Among authors: galanko ja. Cancer Epidemiol Biomarkers Prev. 2003 Aug;12(8):747-54. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 12917206

8

Tea consumption, apoptosis, and colorectal adenomas.

Il'yasova D, Hodgson ME, Martin C, Galanko J, Sandler RS. Il'yasova D, et al. Eur J Cancer Prev. 2003 Oct;12(5):439-43. doi: 10.1097/00008469-200310000-00016. Eur J Cancer Prev. 2003. PMID: 14512812

9

Associations of total energy and macronutrients with colon cancer risk in African Americans and Whites: results from the North Carolina colon cancer study.

Satia-Abouta J, Galanko JA, Potter JD, Ammerman A, Martin CF, Sandler RS; North Carolina Colon Cancer Study. Satia-Abouta J, et al. Among authors: galanko ja. Am J Epidemiol. 2003 Nov 15;158(10):951-62. doi: 10.1093/aje/kwg248. Am J Epidemiol. 2003. PMID: 14607803

10

Food groups and colon cancer risk in African-Americans and Caucasians.

Satia-Abouta J, Galanko JA, Martin CF, Ammerman A, Sandler RS. Satia-Abouta J, et al. Among authors: galanko ja. Int J Cancer. 2004 May 1;109(5):728-36. doi: 10.1002/ijc.20044. Int J Cancer. 2004. PMID: 14999782

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

193 results

Search Page

Filters